Abstract
The advent of organ transplantation has given hope to patients with end-stage organ failure. Allograft rejection is a transplant complication and remains a significant cause of transplant-related morbidity and mortality. Successful transplantation is achieved with immunosuppression, and the discovery of newer immunosuppressive agents has provided transplant physicians with more effective medications in preventing allograft rejection. On the flip side, long-term immunosuppression is fraught with complications such as predisposition to infections, malignancies, and cardiovascular diseases. The patient presented in the case report developed a transplantrelated lymphoma many years after his kidney and pancreatic transplant. Primary care providers should be aware of these complications and educate their patients on measures to prevent some of them.
| Original language | English (US) |
|---|---|
| Article number | e220940C |
| Journal | Annals of Internal Medicine Clinical Cases |
| Volume | 1 |
| Issue number | 8 |
| DOIs | |
| State | Published - Oct 2022 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer prevention
- Cytomegalovirus infection
- Epstein-Barr virus
- Heart-lung transplantation
- Herpes simplex
- Immunosuppressives
- Medical risk factors
- Renal transplantation
- Toxoplasmosis
- Varicella zoster virus
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Internal Medicine
- Clinical Biochemistry
Fingerprint
Dive into the research topics of 'Navigating Through the Complications of Chronic Immunosuppression in Transplant Patients'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS